“…At low concentrations, NMDA potentiates lS,3R-ACPD-stimulated Ins(1,4,5)P3 accumulation, probably by increasing intracellular Ca2" concentration and facilitation of agonist-stimulated PI-PLC activity. These observations suggest that as well as NMDA-receptor/ion channel activity being affected by metabotropic receptor activation (Bleakman et al, 1992;Courtney & Nicholls, 1992;Chen & Huang, 1992;Kelso et al, 1992;Harvey & Collingridge, 1993), reciprocal modulations can also occur, providing additional evidence for the complexities of ionotropic/ metabotropic 'cross-talk' between glutamate receptors which are considered to underlie phenomena such as synaptic plasticity (Madison et al, 1991;Bashir et al, 1993;Behnisch & Reymann, 1993;Bliss & Collingridge, 1993). In contrast, exposure of neonatal cerebral cortex slices to higher concentrations of NMDA causes a rapidly developing inhibition of agonist-stimulated phosphoinositide responses which are most likely to be due to an acute, Ca2"-dependent neurotoxic action of NMDA in this brain preparation.…”